Table 7 Description of sensitivity, specificity and area under the curve (AUC) of the main PsA screening questionnaires
From: Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
Authors | Questionnaires evaluated | Number of participants | Sensitivity | Specificity | AUC |
|---|---|---|---|---|---|
Coates et al., 2018 [31] | CONTEST/ PEST | 159 | PEST 0.72 CONTEST 0.65 | PEST 0.60 CONTEST 0.53 | PEST 0.76 CONTEST 0.71 |
Coates et al., 2016 [20] | CONTEST/CONTESTjt X PEST | 191 | CONTEST 0.76 CONTESTjt 0.76 PEST 0.65 | CONTEST 0.56 CONTESTjt 0.53 PEST 0.53 | CONTEST 0.69 CONTESTjt 0.70 PEST 0.60 |
Duruoz et al., 2018 [32] | TOPAS II X CASPAR | 150 | TOPAS II 0.95 | TOPAS II 0.98 | TOPAS II 0.99 |
You et al., 2015 [27] | PASE X Rheumatologist (based on CASPAR and Moll and Wright) | 148 | PASE 0.77 | PASE 0.82 | PASE 0.79 |
Karreman et al., 2017 [28] | PEST X PASE X EARP X CASPAR | 420 | PEST 0.68 PASE 0.59 EARP 0.87 | PEST 0.71 PASE 0.66 EARP 0.34 | PEST 0.71 PASE 0.64 EARP0.68 |
Audureau et al., 2018 [24] | PURE-4 X CASPAR | 168 | PURE-4 0.85 | PURE-4 0.83 | PURE-4 0.87 |
Salaffi et al., 2018 [25] | SiPAS X CASPAR | 202 | SiPAS 0.79 | SiPAS 0.87 | SiPAS 0.60 |
Iragorri et al., 2019 [31] | PASE X TOPAS X PEST X EARP | 15,208 | PASE 0.66 ToPAS 0.74 PEST 0.66 EARP 0.85 | PASE 0.82 ToPAS 0.79 PEST 0.83 EARP 0.78 | PASE 0.68 ToPAS 0.65 PEST 0.85 EARP 0.85 |